Literature DB >> 12924682

Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression.

Jeanne C Watson1, Laurel B Gordon, Lana Stermac, Freda Kalogerakos, Patricia Steckley.   

Abstract

This study compared process-experiential and cognitive-behavioral psychotherapy in the treatment of major depression in a researcher allegiance-balanced randomized clinical trial. Sixty-six clients participated in weekly sessions of psychotherapy for 16 weeks. Clients' level of depression, self-esteem, general symptom distress, and dysfunctional attitudes significantly improved in both therapy groups. Clients in both groups showed significantly lower levels of reactive and suppressive coping strategies and higher reflective coping at the end of treatment. Although outcomes were generally equivalent for the 2 treatments, there was a significantly greater decrease in clients' self-reports of their interpersonal problems in process-experiential than cognitive-behavioral therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12924682     DOI: 10.1037/0022-006x.71.4.773

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  18 in total

1.  Interpersonal problems as predictors of therapeutic alliance and symptom improvement in cognitive therapy for depression.

Authors:  Fritz Renner; Robin B Jarrett; Jeffrey R Vittengl; Marna S Barrett; Lee Anna Clark; Michael E Thase
Journal:  J Affect Disord       Date:  2012-02-04       Impact factor: 4.839

2.  What we know, what we do not know, and where are we heading? Efficacy and acceptability of psychological interventions for depression.

Authors:  N Solomonov; J P Barber
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-28       Impact factor: 6.892

3.  [Differential indications for psychotherapy exemplified by depression].

Authors:  E Schramm; M Berger
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

4.  The Effect of Telephone-Administered Psychotherapy on Symptoms of Depression and Attrition: A Meta-Analysis.

Authors:  David C Mohr; Lea Vella; Stacey Hart; Timothy Heckman; Gregory Simon
Journal:  Clin Psychol (New York)       Date:  2008

Review 5.  A review of empirically supported psychological therapies for mood disorders in adults.

Authors:  Steven D Hollon; Kathryn Ponniah
Journal:  Depress Anxiety       Date:  2010-10       Impact factor: 6.505

Review 6.  Counselling for mental health and psychosocial problems in primary care.

Authors:  Peter Bower; Sarah Knowles; Peter A Coventry; Nancy Rowland
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

7.  Intraclass correlation associated with therapists: estimates and applications in planning psychotherapy research.

Authors:  Scott A Baldwin; David M Murray; William R Shadish; Sherri L Pals; Jason M Holland; Jonathan S Abramowitz; Gerhard Andersson; David C Atkins; Per Carlbring; Kathleen M Carroll; Andrew Christensen; Kari M Eddington; Anke Ehlers; Daniel J Feaster; Ger P J Keijsers; Ellen Koch; Willem Kuyken; Alfred Lange; Tania Lincoln; Robert S Stephens; Steven Taylor; Chris Trepka; Jeanne Watson
Journal:  Cogn Behav Ther       Date:  2011

8.  Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.

Authors:  Sarah W Kinsinger; Emily Lattie; David C Mohr
Journal:  Neuropsychology       Date:  2010-09       Impact factor: 3.295

Review 9.  [Affective disorders. The significance of psychotherapeutic approaches].

Authors:  M Berger; E L Brakemeier; C Klesse; E Schramm
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

10.  Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression.

Authors:  Stewart A Shankman; Miranda L Campbell; Daniel N Klein; Andrew C Leon; Bruce A Arnow; Rachel Manber; Martin B Keller; John C Markowitz; Barbara O Rothbaum; Michael E Thase; James H Kocsis
Journal:  J Psychiatr Res       Date:  2012-10-25       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.